## Abstract Research and Development investments in the pharmaceutical industry are continuously increasing, resulting in mounting pressure to improve efficiency in terms of output versus cost. Overall, traditional cost accounting methods do not improve effectiveness of pharmaceutical development a
Activity-based costing in pharmaceutical development
✍ Scribed by Stig Jørgensen; Martin Edwards
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 218 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
✦ Synopsis
Pharmaceutical development costs represent a large and escalating part of sales and profits. In many companies, managers have found that the traditional cost accounting methods are not very useful for improving the efficiency and effectiveness of development activities. To complement traditional systems, we propose activity-based costing (ABC) as a powerful tool for helping both to control costs and to provide ideas for reducing lead times. This article reviews the principles of activity-based costing and illustrates the application of these methods to data management processes in clinical development.
📜 SIMILAR VOLUMES
Activity-based costing (ABC) is given much attention in the literature. Most authors seem to agree that improved cost allocations are useful to indicate the long-term profitability of products. However, a controversy starts when the relevance of ABC for short-term decision-making is discussed. This
The role of Small and Medium Enterprises (SMEs) in a national economy has been emphasized all over the world considering their contribution to the total manufacturing output and employment opportunities. Also, SMEs are flexible and innovative taking into account the size and business structure. Henc